Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.78% |
| 2 | Healthcare | 3.27% |
| 3 | Industrials | 2.02% |
| 4 | Financials | 2.02% |
| 5 | Consumer Discretionary | 1.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ICPT
3526
PUT
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $5.08M | ﹤0.01% |
205,800
+44,900
| +28% | +$1.49M |
|
|
RSX
3527
CALL
DELISTED
VanEck Russia ETF
RSX
| $5.08M | ﹤0.01% |
210,400
+14,100
| +7% | +$317K |
|
3528
PUT
Hormel Foods
HRL
$13.5B
| $5.08M | ﹤0.01% |
109,000
+17,300
| +19% | +$844K |
|
3529
Erie Indemnity
ERIE
$13.4B
| $5.08M | ﹤0.01% |
20,679
-21,569
| -51% | -$5.03M |
|
3530
Bakkt Inc
BKKT
$345M
| $5.08M | ﹤0.01% |
+20,189
| New | +$5.03M |
|
3531
PUT
Allegiant Air
ALGT
$2.34B
| $5.07M | ﹤0.01% |
26,800
-23,600
| -47% | -$3.62M |
|
|
NVO
3532
CALL
Novo Nordisk
NVO
$201B
| $5.07M | ﹤0.01% |
145,200
+115,600
| +391% | +$4M |
|
3533
ProShares Ultra Technology
ROM
$1.32B
| $5.07M | ﹤0.01% |
141,526
+89,802
| +174% | +$2.87M |
|
|
SNBR
3534
CALL
DELISTED
Sleep Number
SNBR
| $5.07M | ﹤0.01% |
61,900
+8,300
| +15% | +$576K |
|
3535
iShares Expanded Tech Sector ETF
IGM
$10.9B
| $5.07M | ﹤0.01% |
86,892
-40,176
| -32% | -$2.2M |
|
3536
Personalis
PSNL
$1.5B
| $5.06M | ﹤0.01% |
138,179
-109,893
| -44% | -$3.32M |
|
3537
Invesco FTSE RAFI Developed Markets ex-US Small-Mid ETF
PDN
$369M
| $5.05M | ﹤0.01% |
146,249
+8,538
| +6% | +$273K |
|
3538
Valmont Industries
VMI
$9.56B
| $5.05M | ﹤0.01% |
28,889
-16,946
| -37% | -$2.64M |
|
3539
PUT
iShares MSCI Turkey ETF
TUR
$222M
| $5.05M | ﹤0.01% |
190,600
-15,300
| -7% | -$334K |
|
3540
PUT
AngloGold Ashanti
AU
$48.7B
| $5.05M | ﹤0.01% |
223,100
-106,400
| -32% | -$2.55M |
|
3541
Stepan Co
SCL
$1.48B
| $5.04M | ﹤0.01% |
42,285
+27,267
| +182% | +$3.21M |
|
3542
Unum
UNM
$14.8B
| $5.04M | ﹤0.01% |
219,794
-81,396
| -27% | -$1.68M |
|
|
NGM
3543
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $5.04M | ﹤0.01% |
166,393
+125,036
| +302% | +$2.74M |
|
|
JNPR
3544
CALL
DELISTED
Juniper Networks
JNPR
| $5.04M | ﹤0.01% |
223,900
-211,100
| -49% | -$4.61M |
|
|
RETA
3545
PUT
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $5.03M | ﹤0.01% |
40,700
-8,400
| -17% | -$1.1M |
|
|
CTLT
3546
CALL
DELISTED
CATALENT, INC.
CTLT
| $5.03M | ﹤0.01% |
48,300
+17,600
| +57% | +$1.71M |
|
3547
Wabtec
WAB
$50.5B
| $5.03M | ﹤0.01% |
68,663
-49,717
| -42% | -$3.4M |
|
3548
Fox Factory Holding Corp
FOXF
$883M
| $5.02M | ﹤0.01% |
47,533
-6,217
| -12% | -$565K |
|
3549
Urban Edge Properties
UE
$2.76B
| $5.02M | ﹤0.01% |
388,158
+375,226
| +2,902% | +$4.5M |
|
|
CIM
3550
Chimera Investment
CIM
$988M
| $5.02M | ﹤0.01% |
163,230
-200,510
| -55% | -$5.81M |
|
Similar funds
Ken Griffin's Q4 2020 Portfolio in Review
As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.
- Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Ken Griffin opened 1,988 new positions and closed 1,130 in Q4 2020.
- Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.